Overview
IRD market data
Price History
IRD price chart · 1M
- O
- 4.53
- H
- 4.76
- L
- 4.40
- C
- 4.66
- Vol
- 210,138.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $4.53
- Previous Close
- $4.61
- Day High
- $4.76
- Day Low
- $4.40
- 52 Week High
- $5.22
- 52 Week Low
- $2.82
- 7 Day Return
- +25.95%
- 30 Day Return
- +22.96%
- 90 Day Return
- +15.78%
- 1 Year Return
- -8.98%
- Daily Notional Volume
- $979.2K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.80 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.80 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -1,091.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.24 – $5.81 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $388.5M · P/B 9.03 · P/S 39.42.
Company News
10 captured
Opus Genetics to Present OPGx-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology ConferencesGlobenewswire Inc ·
Opus Genetics Files Prospectus To Sell $300M Mixed Securities Shelf Including 34.5M SharesBenzinga ·
Opus Genetics Q2 EPS $(0.14) Beats $(0.16) Estimate, Sales $755.000K Miss $2.470M EstimateBenzinga ·
8-K filing — Opus Genetics, Inc. (IRD)SEC EDGAR ·